These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2887096)

  • 1. Interventions that potentially limit myocardial infarct size: overview of clinical trials.
    Yusuf S
    Am J Cardiol; 1987 Jul; 60(2):11A-17A. PubMed ID: 2887096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the clinical trials of agents (other than beta-blockers) that potentially limit myocardial infarct size.
    Yusuf S
    J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S48-55. PubMed ID: 2468835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infarct size reduction: a review of the clinical trials.
    Campbell CA; Przyklenk K; Kloner RA
    J Clin Pharmacol; 1986; 26(5):317-29. PubMed ID: 2871053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions during and after acute myocardial infarction.
    Sleight P
    Postgrad Med J; 1983; 59 Suppl 3():80-8. PubMed ID: 6139802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial salvage by medical therapy in acute myocardial infarction.
    Col JJ
    Bibl Cardiol; 1985; (39):97-104. PubMed ID: 2877657
    [No Abstract]   [Full Text] [Related]  

  • 6. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
    Yusuf S; Sleight P; Held P; McMahon S
    Circulation; 1990 Sep; 82(3 Suppl):II117-34. PubMed ID: 1975522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
    Yusuf S
    Chest; 1988 Jan; 93(1 Suppl):25S-28S. PubMed ID: 2891466
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction.
    Held PH; Yusuf S
    Eur Heart J; 1993 Oct; 14 Suppl F():18-25. PubMed ID: 7903243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary prevention in the post-infarction period].
    Corea L; Bentivoglio M
    Cardiologia; 1989 Feb; 34(2):127-33. PubMed ID: 2567624
    [No Abstract]   [Full Text] [Related]  

  • 10. Efforts to limit the size of myocardial infarcts.
    Rude RE; Muller JE; Braunwald E
    Ann Intern Med; 1981 Dec; 95(6):736-61. PubMed ID: 6118084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of acute myocardial infarction without cardiogenic shock and thrombolytic therapy excluded].
    Roul G; Bareiss P; Mossard JM; Sacrez A
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):763-71. PubMed ID: 1356327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.
    Yusuf S; Wittes J; Friedman L
    JAMA; 1988 Oct; 260(14):2088-93. PubMed ID: 2901501
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological profile of survivors of acute myocardial infarction at Turkish academic hospitals.
    Ergin A; Abaci A; Sakalli A; Eryol NK; Oguzhan A; Unal S; Cetin S
    Int J Cardiol; 1999 Mar; 68(3):309-16. PubMed ID: 10213283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective drugs in preventing recurrent coronary events. I. Hospital phase.
    Rapaport E
    Adv Cardiol; 1986; 33():1-8. PubMed ID: 2882650
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
    Opie LH
    Am Heart J; 1980 Oct; 100(4):531-52. PubMed ID: 6106384
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myocardial infarction: state of the art.
    Jaffe AS
    Circulation; 1986 Dec; 74(6 Pt 2):IV120-3. PubMed ID: 2877752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?].
    Delahaye F; Genoud JL; Colin C; Landrivon G; Ecochard R; Desseigne P; Pinzani A; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1567-74. PubMed ID: 1363772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy in acute myocardial infarction: review of clinical trials.
    Rentrop KP; Cohen M; Hosat ST
    Am J Cardiol; 1984 Dec; 54(11):29E-31E. PubMed ID: 6439024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic limitation of the size of the myocardial infarction (excluding thrombolysis)].
    Zannad F; Gilgenkrantz JM; Royer RJ
    Ann Cardiol Angeiol (Paris); 1985; 34(7):467-73. PubMed ID: 2865926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.